Skip Navigation

Cardiovascular Research 1998 38(1):221-228; doi:10.1016/S0008-6363(98)00008-X
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Newby, D. E.
Right arrow Articles by Webb, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newby, D. E.
Right arrow Articles by Webb, D. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Peripheral vascular tone in patients with cirrhosis: role of the renin–angiotensin and sympathetic nervous systems

David Ernest Newbya,b,*, Rajiv Jalanc, Satoko Masumoria,1, Peter Clive Hayesc, Nicholas Antony Boonb and David John Webba

aClinical Pharmacology Unit and Research Centre, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, Scotland, UK
bDepartment of Cardiology, University of Edinburgh, Royal Infirmary, Lauriston Place, Edinburgh EH3 9YW, Scotland, UK
cDepartment of Medicine, University of Edinburgh, Royal Infirmary, Lauriston Place, Edinburgh EH3 9YW, Scotland, UK

* Corresponding author. Tel.: +44 (131) 332 1205; Fax: +44 (131) 343 6017; E-mail: d.e.newby@ed.ac.uk

Objective: The aims of the study were to establish the roles of angiotensin II and of the cardiopulmonary baroreceptor reflex in the regulation of peripheral vascular tone in patients with cirrhosis. Methods: Forearm blood flow responses to subsystemic, locally active intrabrachial infusions were measured in patients with Child's Grade C cirrhosis and matched controls using bilateral venous occlusion plethysmography. Responses were determined to the angiotensin II type I receptor antagonist, losartan, noradrenaline, angiotensin II and the nitric oxide synthase inhibitor, L-NG-monomethyl arginine. Results: Losartan at 30 and 90 µg/min caused no significant change in blood flow in controls, but caused 23±6% and 27±5% increases in patients respectively (p<0.001). Lower body negative pressure caused a mean bilateral reduction in forearm blood flow of 20±4% in controls (p<0.001) but only tended to reduce flow (9±5%; p=0.06) in patients (p<0.001; controls vs. patients). Noradrenaline, angiotensin II and L-NG-monomethyl arginine caused significant vasoconstriction (p<0.001) in both patients and controls although angiotensin II caused significantly less vasoconstriction in patients (p=0.01). Conclusions: We conclude that angiotensin II makes an important contribution to basal peripheral vascular tone in patients with cirrhosis in the face of reduced vascular responses to its local administration. In addition, the vasoconstrictor response to cardiopulmonary baroreceptor unloading is attenuated despite normal vascular responses to noradrenaline. These responses are consistent with chronic activation of the renin–angiotensin and sympathetic nervous systems in patients with advanced cirrhosis.

KEYWORDS Angiotensin; Regional blood flow; Renin angiotensin system; Adrenergic agonists; Autonomic nervous system


1 Present address: Yokohama City University, School of Medicine, Second Department of Internal Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama 236, Japan.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GutHome page
J W Ferguson, A R Dover, S Chia, N L M Cruden, P C Hayes, and D E Newby
Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites
Gut, April 1, 2006; 55(4): 542 - 546.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G Paizis, C Tikellis, M E Cooper, J M Schembri, R A Lew, A I Smith, T Shaw, F J Warner, A Zuilli, L M Burrell, et al.
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
Gut, December 1, 2005; 54(12): 1790 - 1796.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Veelken, K. F. Hilgers, M. Porst, H. Krause, A. Hartner, and R. E. Schmieder
Effects of sympathetic nerves and angiotensin II on renal sodium and water handling in rats with common bile duct ligature
Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1267 - F1275.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Goddard, N. R. Johnston, M. F. Hand, A. D. Cumming, T. J. Rabelink, A. J. Rankin, and D. J. Webb
Endothelin-A Receptor Antagonism Reduces Blood Pressure and Increases Renal Blood Flow in Hypertensive Patients With Chronic Renal Failure: A Comparison of Selective and Combined Endothelin Receptor Blockade
Circulation, March 9, 2004; 109(9): 1186 - 1193.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R B Vaughan, P W Angus, and J P F Chin-Dusting
Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation
Gut, October 1, 2003; 52(10): 1505 - 1510.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S C Apostolopoulou, S Rammos, Z S Kyriakides, D J Webb, N R Johnston, D V Cokkinos, and D T. Kremastinos
Acute endothelin A receptor antagonism improves pulmonary and systemic haemodynamics in patients with pulmonary arterial hypertension that is primary or autoimmune and related to congenital heart disease
Heart, October 1, 2003; 89(10): 1221 - 1226.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
A Helmy, D E Newby, R Jalan, P C Hayes, and D J Webb
Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide
Gut, March 1, 2003; 52(3): 410 - 415.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
D.E. Newby and P.C. HAYES
Hyperdynamic circulation in liver cirrhosis: not peripheral vasodilatation but 'splanchnic steal'
QJM, December 1, 2002; 95(12): 827 - 830.
[Full Text] [PDF]


Home page
GutHome page
J H Henriksen, S Moller, S Schifter, J Abrahamsen, and U Becker
High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems
Gut, July 1, 2001; 49(1): 112 - 118.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R JALAN, D E NEWBY;, F WONG, and L BLENDIS
Losartan and renal sodium handling Reply
Gut, October 1, 2000; 47(4): 596a - 597.
[Full Text] [PDF]


Home page
GutHome page
R Jalan and P C Hayes
Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure
Gut, April 1, 2000; 46(4): 527 - 533.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. V. Bilfinger and G. B. Stefano
Human aortocoronary grafts and nitric oxide release: relationship to pulsatile pressure
Ann. Thorac. Surg., February 1, 2000; 69(2): 480 - 485.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. E. Strachan, J. C. Spratt, I. B. Wilkinson, N. R. Johnston, G. A. Gray, and D. J. Webb
Systemic Blockade of the Endothelin-B Receptor Increases Peripheral Vascular Resistance in Healthy Men
Hypertension, January 1, 1999; 33(1): 581 - 585.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.